Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/annrheumdis-2020-218075 http://scihub22266oqcxt.onion/10.1136/annrheumdis-2020-218075 32591357!ä!32591357 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Rheum+Dis 2021 ; 80 (5): e67 Nephropedia Template TP {{tp|p=32591357|t=2021. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab |pdf=|usr=}}{{32591357}} gab.com Text Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab JO: Ann Rheum Dis http://www.kidney.de/pget.php?&tw=1&pmid=32591357 #FOAvip ä Twit Text FOAVip Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab ????Ann Rheum Dis http://www.kidney.de/pget.php?&tw=1&pmid=32591357 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32591357 #FOAvip English Wikipedia <ref>{{Cite pmid|32591357}}</ref> Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab #MMPMID32591357 Schulze-Koops H; Krueger K; Vallbracht I; Hasseli R; Skapenko A Ann Rheum Dis 2021[May]; 80 (5): e67 PMID32591357show ga ä |*Antirheumatic Agents/adverse effects[MESH] |*Arthritis, Rheumatoid/drug therapy[MESH] |*COVID-19[MESH] |Humans[MESH] |Rituximab/therapeutic use[MESH]Increased risk for severe COVID-19 in patients with inflammatory rheum(epmc).pdf DeepDyve Pubget Overpricing